Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease

Angiology

Volumn 65, Issue 3, 2014, Pages 227-231

  Uysal, Onur Kadir ^a   Sahin, Durmus Yildiray ^b   Duran, Mustafa ^a   Turkoglu, Caner ^b   Yildirim, Arafat ^b   Elbasan, Zafer ^b   Ozkan, Bugra ^b   Tekin, Kamuran ^b   Kunak, Aysegul Ulgen ^a   Yilmaz, Yucel ^a   Kaya, Mehmet Gungor ^c   Gur, Mustafa ^b   Cayli, Murat ^b  

^a Kayseri Education and Research Hospital ^*  (Turkey)

^b ADANA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

coronary angiography; coronary artery disease; coronary collateral circulation; uric acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY DISEASE; CORONARY ARTERY OCCLUSION; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; URIC ACID BLOOD LEVEL;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY COLLATERAL CIRCULATION; URIC ACID;

BIOLOGICAL MARKERS; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; URIC ACID;

EID: 84893609417     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713500706     Document Type: Article

References (31)

1. Berry C, Balachandran KP, L'Allier PL, Lespérance J, Bonan R, Oldroyd KG. Importance of collateral circulation in coronary heart disease. Eur Heart J. 2007 ; 28 (3). 278-291
2. Kersten JR, Pagel PS, Chilian WM, Warltier DC. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia [review]. Cardiovasc Res. 1999 ; 43 (1). 44-57
3. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005 ; 16 (12). 3553-3562
4. Mercuro G, Vitale C, Cerquetani E, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004 ; 94 (7). 932-935
5. Kasapkara HA, Topsakal R, Yarlioglues M, et al. Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis. 2012 ; 23 (7). 421-425
6. Duran M, Ornek E, Murat SN, et al. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology. 2012 ; 63 (6). 472-475
7. Duran M, Murat SN, Ornek E. Does serum uric acid level affect coronary collaterals in patients with acute coronary syndrome?. Angiology. 2013 ; 64 (4). 325-326
8. Hsu PC, Su HM, Lin TH. Association between coronary collaterals and serum uric acid level in Chinese population with acute coronary syndrome. Angiology. 2013 ; 64 (4). 323-324
9. Duran M, Kalay N, Akpek M, et al. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology. 2012 ; 63 (6). 448-452
10. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985 ; 5 (3). 587-592
11. Celik T, Celik M, Iyisoy A. Coronary collateral circulation. Turk Kardiyol Dern Ars. 2010 ; 38 (7). 505-514
12. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U.. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA augsburg cohort. World health organization monitoring trends and determinants in cardiovascular diseases. Epidemiology. 1999 ; 10 (4). 391-397
13. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National health and nutrition examination survey. JAMA. 2000 ; 283 (18). 2404-2410
14. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?. Atherosclerosis. 2000 ; 148 (1). 131-139
15. Krishnan E, Pandya BJ, Chung L, Dabbous O. Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study. Arthritis Res Ther. 2011 ; 13 (2). R66
16. Bickel C, Rupprecht HJ, Blankenberg S, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol. 2002 ; 89 (1). 12-17
17. Okura T, Higaki J, Kurata M, et al. Japanese coronary artery disease study investigators. elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese coronary artery disease (JCAD) study. Circ J. 2009 ; 73 (5). 885-891
18. Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011 ; 219 (1). 334-341
19. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol. 2007 ; 293 (2). 584-596
20. Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008 ; 295 (5). 1183-1190
21. Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol. 2006 ; 290 (3). 625-631
22. Yu MA, Sánchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010 ; 28 (6). 1234-1242
23. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002 ; 13 (12). 2888-2897
24. Schirmer SH, van Royen N, Moerland PD, et al. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J Am Coll Cardiol. 2009 ; 53 (23). 2141-2147
25. Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. Eur J Endocrinol. 2010 ; 163 (3). 469-477
26. Kanbay M, Sánchez-Lozada LG, Franco M, et al. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant. 2011 ; 26 (2). 430-437
27. Patetsios P, Song M, Shutze WP, et al. Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol. 2001 ; 88 (2). 188-191
28. Seiler C, Stoller M, Pitt B, Meier P Eur Heart J. 2013 :
29. Kadi H, Ceyhan K, Karayakali M, et al. Effects of prediabetes on coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis. 2011 ; 22 (4). 233-237
30. Mouquet F, Cuilleret F, Susen S, et al. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1. Eur Heart J. 2009 ; 30 (7). 840-849
31. Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M. Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. Curr Pharm Des. 2005 ; 11 (32). 4161-4175